Maryam Lustberg
#116,941
Most Influential Person Now
American breast oncologist
Maryam Lustberg's AcademicInfluence.com Rankings
Maryam Lustbergphilosophy Degrees
Philosophy
#11075
World Rank
#15207
Historical Rank
Logic
#7894
World Rank
#9821
Historical Rank
Download Badge
Philosophy
Maryam Lustberg's Degrees
- Doctorate Medicine University of Medicine and Dentistry of New Jersey
- Masters Clinical Research Rutgers University
Why Is Maryam Lustberg Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maryam Beheshti Lustberg is an American breast oncologist. She is the Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center. Lustberg previously served as the Medical Director of Supportive Care at Ohio State's Comprehensive Cancer Center and President-Elect of the Multinational Association of Supportive Care in Cancer. She is also an associate editor for the peer-reviewed medical journal covering oncology nursing with respect to cancer survivors called Journal of Cancer Survivorship. Lustberg was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.
Maryam Lustberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study (2020) (1264)
- Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. (2014) (910)
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. (2020) (291)
- Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium (2021) (178)
- Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck (2012) (109)
- Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells (2015) (97)
- Addressing the needs of cancer survivors during the COVID-19 pandemic (2020) (94)
- Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients (2014) (94)
- Bone health in adult cancer survivorship. (2012) (90)
- Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update. (2019) (79)
- Management of neutropenia in cancer patients. (2012) (74)
- Platinum‐induced peripheral neurotoxicity: From pathogenesis to treatment (2019) (72)
- Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients (2017) (65)
- Emerging technologies for CTC detection based on depletion of normal cells. (2012) (64)
- Atrophic Vaginitis in Breast Cancer Survivors: A Difficult Survivorship Issue (2015) (61)
- Breast cancer and social environment: getting by with a little help from our friends (2016) (61)
- Immune checkpoint inhibitors‐induced neuromuscular toxicity: From pathogenesis to treatment (2019) (61)
- CSF1-ETS2 Induced microRNA in Myeloid Cells Promote Metastatic Tumor Growth (2014) (60)
- A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer. (2018) (60)
- Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. (2019) (54)
- PD‐L1 expression and CD8‐positive T cells are associated with favorable survival in HER2‐positive invasive breast cancer (2018) (53)
- Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer (2017) (52)
- TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer (2014) (52)
- Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy (2019) (51)
- Chemotherapy‐induced peripheral neurotoxicity: A multifaceted, still unsolved issue (2019) (48)
- Optimal Duration of Chemotherapy in Advanced Non-Small Cell Lung Cancer (2007) (47)
- Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials. (2015) (47)
- Management options for established chemotherapy-induced peripheral neuropathy (2014) (47)
- OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity (2018) (47)
- Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview (2019) (46)
- FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma (2008) (46)
- Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group (2020) (44)
- Isolation and analysis of rare cells in the blood of cancer patients using a negative depletion methodology. (2013) (41)
- Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor (2020) (38)
- Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment (2019) (38)
- Triple-negative breast cancer: promising prognostic biomarkers currently in development (2020) (37)
- Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach. (2015) (36)
- Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors (2019) (36)
- Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice. (2020) (35)
- Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer (2010) (34)
- Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies. (2019) (33)
- Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women (2018) (33)
- Diet Quality, Inflammation, and Quality of Life in Breast Cancer Survivors: A Cross-Sectional Analysis of Pilot Study Data. (2017) (32)
- Epigenetic Therapy in Breast Cancer (2011) (32)
- Effects of exercise interventions during different treatments in breast cancer. (2016) (30)
- Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review (2013) (30)
- Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival‐, apoptosis‐related molecules and microenvironment in tumors (2013) (30)
- Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study. (2016) (30)
- Targeting OCT3 attenuates doxorubicin-induced cardiac injury (2021) (28)
- Pilot randomized controlled trial of a symptom cluster intervention in advanced cancer (2018) (28)
- Risk factors for anthracycline-associated cardiotoxicity (2016) (28)
- Epigenetic targeting in breast cancer: therapeutic impact and future direction. (2009) (27)
- Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer. (2020) (27)
- Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer. (2015) (27)
- Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer. (2011) (26)
- Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer. (2014) (25)
- Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors (2019) (25)
- Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy (2012) (22)
- Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes (2012) (22)
- Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction (2015) (22)
- Multidisciplinary patient-centered management of brain metastases and future directions (2020) (21)
- Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study (2019) (21)
- Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer (2020) (21)
- Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm (2017) (21)
- Pleiotropic effects of nutritional ketosis: Conceptual framework for keto-adaptation as a breast cancer therapy (2017) (20)
- Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair. (2016) (20)
- Readdressing the Needs of Cancer Survivors During COVID-19: A Path Forward (2020) (20)
- Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy (2013) (20)
- Phase I trial of the PARP inhibitor veliparib (V) in combination with carboplatin (C) in metastatic breast cancer (MBC). (2014) (19)
- Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction (2011) (19)
- Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare? (2020) (19)
- A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance (2020) (19)
- Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors. (2021) (19)
- Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain (2018) (19)
- Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma (2010) (18)
- Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic (2021) (18)
- Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study (2020) (17)
- An overview of the unique challenges facing African-American breast cancer survivors (2018) (17)
- Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN). (2021) (16)
- Advances and future directions in the use of mobile health in supportive cancer care: proceedings of the 2019 MASCC Annual Meeting symposium (2020) (16)
- Worry and rumination in breast cancer patients: perseveration worsens self-rated health (2020) (16)
- Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (2021) (16)
- A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer (2020) (16)
- Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance. (2019) (16)
- Psychoneurological symptom cluster in breast cancer: the role of inflammation and diet (2020) (16)
- The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment (2020) (15)
- A first-in-human phase I trial of AR-12, a PDK-1 inhibitor, in patients with advanced solid tumors. (2013) (14)
- A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer (2014) (14)
- Financial Burden of Drugs Prescribed for Cancer-Associated Symptoms (2021) (13)
- Usefulness of Integrating Heart Failure Risk Factors Into Impairment of Global Longitudinal Strain to Predict Anthracycline-Related Cardiac Dysfunction. (2018) (13)
- Role of SLC transporters in toxicity induced by anticancer drugs (2020) (12)
- Physical Activity After Breast Cancer Surgery: Does Depression Make Exercise Feel More Effortful than It Actually Is? (2019) (12)
- Abstract LB-216: NCI 9455: Phase II study of trametinib followed by trametinib plus AKT inhibitor,GSK2141795 in patients with advanced triple negative breast cancer (2016) (12)
- Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy. (2021) (12)
- Exploring the Roles of Central and Peripheral Nervous System Function in Gait Stability: Preliminary Insights from Cancer Survivors. (2019) (12)
- Dietary Long-Chain n-3 Fatty Acid Intake and Arthritis Risk in the Women's Health Initiative. (2018) (11)
- An Evaluation of Factors Predicting Diet Quality among Cancer Patients (2018) (11)
- Future research in cancer survivorship (2021) (11)
- Treatment-related mortality with everolimus in cancer patients. (2014) (11)
- Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series (2021) (11)
- Primary care physicians’ perspectives of the survivorship care for older breast cancer survivors: a pilot study (2019) (11)
- Partnered, adapted argentine tango dance for cancer survivors: A feasibility study and pilot study of efficacy. (2019) (10)
- Pneumocystis jiroveci Pneumonia in an Atypical Host. (2012) (10)
- Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer (2020) (10)
- A MagDot-Nanoconveyor Assay Detects and Isolates Molecular Biomarkers. (2012) (10)
- Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States. (2020) (10)
- Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges (2018) (10)
- Low Sucrose, Omega-3 Enriched Diet Has Region-Specific Effects on Neuroinflammation and Synaptic Function Markers in a Mouse Model of Doxorubicin-Based Chemotherapy (2018) (10)
- Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer (2015) (10)
- Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin (2014) (9)
- Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis (2016) (9)
- TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature (2020) (9)
- Effects of tandem cognitive behavioral therapy and healthy lifestyle interventions on health-related outcomes in cancer survivors: a systematic review (2021) (8)
- Learning, Life, and Lactation: Knowledge of Breastfeeding's Impact on Breast Cancer Risk Reduction and Its Influence on Breastfeeding Practices. (2018) (8)
- Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study (2020) (7)
- Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion (2021) (7)
- Effect of chemotherapy-induced peripheral neuropathy on postural control in cancer survivors. (2017) (7)
- Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer (2020) (7)
- Palliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer Center. (2020) (7)
- Introduction to special section: Living with Incurable Cancer: Addressing Gaps in Cancer Survivorship (2021) (7)
- Perspectives of Survivorship Care Plans Among Older Breast Cancer Survivors: A Pilot Study (2019) (7)
- Feasibility of implementing a text-based symptom-monitoring program of endometrial, ovarian, and breast cancer patients during treatment (2020) (6)
- Association of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer. (2020) (6)
- Dissemination of cancer survivorship care plans: who is being left out? (2021) (6)
- Delay discounting and adjuvant endocrine therapy adherence in hormone receptor-positive breast cancer. (2021) (6)
- Metastatic breast cancer patient perceptions of somatic tumor genomic testing (2019) (6)
- Oncologists' Perceptions of a Digital Tool to Improve Cancer Survivors' Cardiovascular Health (2019) (6)
- A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study (2021) (6)
- Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither? (2020) (6)
- Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy (2022) (6)
- Primary care physician’s confidence and coordination regarding the survivorship care for older breast cancer survivors (2020) (5)
- Surgical Management of Breast Cancer Liver Metastasis. (2021) (5)
- Long-Term Follow-Up of Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (2022) (5)
- Time for Action: Managing Genitourinary Syndrome of Menopause. (2019) (5)
- Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It? (2022) (5)
- Supportive Care: Low Cost, High Value. (2021) (5)
- Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions. (2019) (5)
- Perspectives of adolescent and young adult cancer survivors: review of community-based discussion boards (2021) (5)
- Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. (2016) (4)
- Advanced stage breast cancer is associated with catheter-tip thrombus formation following implantable central venous port placement (2019) (4)
- Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primary (2015) (4)
- Anthracycline Cardiotoxicity: How Do We Move From Diagnosis to Prediction? (2016) (4)
- Genomic features of rapid versus late relapse in triple negative breast cancer (2021) (4)
- Assessment of Food Safety Knowledge and Behaviors of Cancer Patients Receiving Treatment (2019) (4)
- Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia (2020) (4)
- Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer (2022) (4)
- Risk factors for anthracycline-associated cardiotoxicity. (2014) (4)
- Novel Balance Interventions for Chemotherapy-Induced Peripheral Neuropathy: Argentine Tango (2016) (3)
- A phase Ib adaptive study of dasatinib for the prevention of oxaliplatin-induced neuropathy in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy and bevacizumab. (2020) (3)
- Strategies to mitigate the toxicity of cancer therapeutics. (2022) (3)
- A precision medicine approach to metabolic therapy for breast cancer in mice (2021) (3)
- Cognitive problems of breast cancer survivors on proton pump inhibitors (2020) (3)
- A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring (2022) (3)
- Remarkable response to a novel ATR inhibitor in a patient with poorly differentiated neuroendocrine carcinoma. (2018) (3)
- Effects of chemotherapy on quality of life in breast cancer survivors. (2015) (3)
- Genomic features of rapid versus late relapse in triple negative breast cancer (2021) (3)
- Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer (2021) (3)
- Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience (2020) (3)
- The Global POLAR program: Calmangafodipir used on top of modified FOLFOX6 (5-FU/FA and oxaliplatin) to prevent chemotherapy induced peripheral neuropathy (CIPN). (2019) (2)
- Effects of plant-based versus marine-based omega-3 fatty acids and sucrose on brain and liver fatty acids in a mouse model of chemotherapy (2021) (2)
- Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase (CDK) 4/6 inhibitor use. (2021) (2)
- Erythrocyte Long-Chain ω-3 Fatty Acids Are Positively Associated with Lean Mass and Grip Strength in Women with Recent Diagnoses of Breast Cancer. (2021) (2)
- Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer (2018) (2)
- Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions (2022) (2)
- Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias (2021) (2)
- Abstract P4-09-18: Characterization of circulating myeloid derived suppressor cells and cytokines in patients undergoing neo-adjuvant chemotherapy for breast cancer (2016) (2)
- Abstract P1-09-03: Prevention of aromatase Inhibitor (AI)-induced joint symptoms with omega-3 fatty acid supplementation: A randomized placebo-controlled pilot study (2015) (2)
- Mitigating acute chemotherapy-associated adverse events in patients with cancer (2022) (2)
- Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer. (2012) (2)
- Machine learning predicts rapid relapse of triple negative breast cancer (2019) (2)
- The Global POLAR program: Two pivotal placebo-controlled studies of calmangafodipir used on top of modified FOLFOX6 to prevent chemotherapy-induced peripheral neuropathy (CIPN). (2019) (2)
- The Effects of Doxorubicin-based Chemotherapy and Omega-3 Supplementation on Mouse Brain Lipids (2019) (2)
- Breast cancer survivors’ typhoid vaccine responses: Chemotherapy, obesity, and fitness make a difference (2022) (2)
- SO-17 The global POLAR program: Top-line results of placebo-controlled studies of calmangafodipir on top of modified FOLFOX6 to prevent chemotherapy-induced peripheral neuropathy (2021) (2)
- Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions. (2020) (2)
- Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M) (2022) (2)
- Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience (2020) (2)
- Healthy Eating Index Scores are Associated with Inflammatory Markers in Breast Cancer Survivors (2015) (2)
- Cardiovascular Event Reporting in Modern Cancer Radiation Therapy Trials (2021) (2)
- Decision impact analysis of comprehensive genomic profiling (CGP) in advanced breast cancer: A prospective study. (2016) (2)
- Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients (2022) (2)
- Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female Controls. (2020) (2)
- Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy. (2020) (2)
- Abstract P2-13-01: Quality of life in survivors of stage I-II breast cancer, 10 years outcome of a randomized clinical trial comparing post-operative hypofractionation with Tomotherapy versus conventional radiation treatment (TomoBreast) (2020) (2)
- Utilization of an audit tool to evaluate accuracy of treatment summary and survivorship care plans (2019) (2)
- The COVID-19 & Cancer Consortium (CCC19) and Opportunities for Radiation Oncology (2020) (2)
- Current Fertility Preservation Options for Female Patients With Hodgkin Lymphoma (2020) (2)
- Scheduling Delayed Treatment and Surgeries Post-Pandemic: A Stakeholder Analysis (2020) (1)
- Effects of Omega-3 Fatty Acids on Brain Fatty Acids and Associations with Glucose Metabolism and Anxiety-Like Behavior in an Ovariectomized Mouse Model of Chemotherapy (2020) (1)
- Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience. (2021) (1)
- REPORTING OF CARDIOVASCULAR EVENTS IN CLINICAL TRIALS SUPPORTING FDA-APPROVAL OF CONTEMPORARY CANCER DRUGS (2019) (1)
- Effects of Sucrose and Omega-3 Fatty Acids on Chemotherapy-Induced Neuroinflammation in a Mouse Model of Breast Cancer (2015) (1)
- PROMIS-10 scores at six months post-baseline among breast and gynecologic oncology patients participating in a text-based symptom monitoring program with patient navigation. (2020) (1)
- Typhoid vaccine does not impact feelings of social connection or social behavior in a randomized crossover trial among middle-aged female breast cancer survivors (2022) (1)
- Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples. (2017) (1)
- A phase I study of neoadjuvant chemotherapy (NCT) with the gamma secretase (GS) inhibitor RO4929097 in combination with paclitaxel (P) and carboplatin (C) in women with triple-negative breast cancer (TNBC). (2013) (1)
- Abstract P1-09-30: Relationship of dietary and red blood cell polyunsaturated fatty acids to inflammatory markers in breast cancer survivors taking aromatase inhibitors (2015) (1)
- Examining the Association of Billed Advance Care Planning With End-of-Life Hospital Admissions Among Advanced Cancer Patients in Hospice (2021) (1)
- Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients (2014) (1)
- Changes in Inflammatory Markers and Correlations with Serum Polyunsaturated Fatty Acids In Postmenopausal Women With Breast Cancer Undergoing Chemotherapy (2021) (1)
- A Human Factors Perspective to Characterize Treatment and Surgery During the COVID-19 Pandemic (2020) (1)
- Real-world data on usage of scalp cooling for chemotherapy associated alopecia in the United States. (2021) (1)
- NCI 8609: Interim fluoro-3’-deoxythymidine (FLT) PET imaging findings from the phase I trial of PARP inhibitor veliparib (V) and carboplatin (C) in advanced breast cancer. (2013) (1)
- The impact of granulocyte colony-stimulating factor use in patients with metastatic breast cancer treated with palliative chemotherapy: a single-institution retrospective review (2020) (1)
- The Rise of Supportive Oncology: A Revolution in Cancer Care. (2023) (1)
- Associations of Long Chain Polyunsaturated Fatty Acid Biomarkers with Affective Symptoms and Cognition in Women Beginning Chemotherapy for Breast Cancer (2020) (1)
- Effect of an Argentine Tango Intervention on Gait Variability in Cancer Survivors: 2413 Board #4 June 2 9 (2017) (1)
- Abstract P4-10-09: Patient-centered dosing: Oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC) (2022) (1)
- Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis (2022) (1)
- Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine (HER2CLIMB). (2020) (1)
- ‘Share your views’—international consultation informs a patient engagement strategy for the Multinational Association of Supportive Care in Cancer (2022) (1)
- Initial Feasibility And Acceptability Of A Community-based Lifestyle Intervention Among Breast Cancer Survivors (2021) (1)
- EpCAM-negative cancer-associated circulating cells (CACS) in blood samples of women with triple-negative breast cancer (TNBC). (2011) (1)
- Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study (2021) (1)
- Factors Associated with Food Safety Behaviors in Cancer Patients Seeking Treatment (2017) (1)
- A phase Ib study of the safety and pharmacology of nilotinib to prevent paclitaxel-induced peripheral neuropathy in patients with breast cancer. (2020) (1)
- Abstract 3284: Isolation of circulating tumor cells (CTCs) with mesenchymal and stem cell markers in localized and metastatic breast cancer using a novel negative selection enrichment (2010) (1)
- THU0062 Novel animal model of aromatase inhibitor-induced arthralgia suggests an estrogen-independent inflammatory mechanism (2017) (1)
- Aromatase-Inhibitor-Induced Musculoskeletal Inflammation Is Observed Independent of Oophorectomy in a Novel Mouse Model (2022) (1)
- Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women (2018) (1)
- Phase Ib study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple-negative breast cancer (NCT02474173). (2017) (1)
- Abstract P1-09-01: CD8+ T-cell gene expression and signatures in breast cancer and adjacent normal breast tissue: Association with body mass index, alcohol intake, and age at diagnosis (2019) (1)
- Abstract SS2-05: Emerging from COVID-19 pandemic: Provider perspective on use of neoadjuvant endocrine therapy (NET) in early stage hormone receptor positive breast cancer (2021) (1)
- An omega-3 Fatty Acid Enriched Diet Reduces Anxiety-like Behavior While High Dietary Sucrose During Chemotherapy Increases Anxiety-like Behavior in Mice (P14-023-19). (2019) (1)
- Effects Of A Community-Based Lifestyle Intervention On Resistance Training And Balance Outcomes Among Breast Cancer Survivors (2021) (0)
- BPI21-008: Patient Preferences and Treatment Adherence to Adjuvant Ovarian Suppression Among Premenopausal Women With Hormone Receptor Positive Breast Cancer (2021) (0)
- Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity (2022) (0)
- Abstract 4786: Cellular localization of PRMT5 correlates with poor recurrent free survival in triple-negative breast cancer (TNBC) (2015) (0)
- Strategic planning for implementation of Commission on Cancer standard 3.3 in a tertiary academic center. (2018) (0)
- Assessment of Leptomeningeal Carcinomatosis Diagnosis and Outcomes from 2005 to 2015 at Ohio State University. (2019) (0)
- Survival outcomes by hormone receptor expression in early-stage HER2-positive breast cancer. (2019) (0)
- Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer (2020) (0)
- Right Sizing Systemic Therapy for Patients with Breast Cancer. Where are we Today? (2022) (0)
- Abstract PS13-46: Immunomodulation with dexamethasone in neoadjuvant chemotherapy for triple negative breast cancer (2021) (0)
- Differential Contribution of Neuronal Uptake Transporters to Oxaliplatin Peripheral Neurotoxicity (2020) (0)
- Breast cancer and social environment: getting by with a little help from our friends (2016) (0)
- Abstract P3-09-09: Serial circulating tumor DNA from patients with metastatic breast cancer with and without BRCA1/2 mutations (2022) (0)
- Abstract 5514: Analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients pre- and post-neoadjuvant chemotherapy for operable breast cancer (2020) (0)
- Levering internet-based discussion data from gynecological cancer survivors to inform survivorship care: A mixed methods thematic analysis approach. (2022) (0)
- CLO19-027: Assessment of Metastatic Invasive Lobular Carcinoma Management and Outcomes From 2004-2014: A Single Institution Experience (2019) (0)
- Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021 (2022) (0)
- Title: A Precision Medicine Approach to Metabolic Therapy for Breast Cancer in Mice (2021) (0)
- Phase II and pharmacogenetic study of docetaxel (D) and capecitabine (C) in chemonaive non-small cell lung cancer (NSCLC) patients (pts) (2008) (0)
- Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701). (2023) (0)
- Case Study in Chemotherapy-Induced Neuropathy: Tango Dance Improved Over-Ground Local Gait Stability (2023) (0)
- Palliative care referral patterns of adolescent and young adult patients at a comprehensive cancer center. (2019) (0)
- Developing a global cancer survivorship community: the Journal of Cancer Survivorship Social Media Site @jcansurv (2021) (0)
- Abstract P4-10-11: Eyebrow/eyelash loss among survivors (2022) (0)
- Racial and ethnic disparities among patients with breast cancer and COVID-19. (2021) (0)
- Phase II double blinded randomized placebo-controlled trial of minocycline to ameliorate chemotherapy-induced cognitive changes in breast cancer (BC) patients. (2021) (0)
- 2022 Annual Meeting of The North American Menopause Society October 12 - 15, 2022, Atlanta, GA. (2022) (0)
- Abstract P2-20-07: Assessment of leptomeningeal carcinomatosis management and outcomes in patients with advanced breast cancer from 2005 to 2015: A single institution experience (2020) (0)
- Abstract 5586: Phase I study of PARP inhibitor ABT-888 and carboplatin with novel imaging in metastatic breast cancer (MBC) (NCI-8609) (2012) (0)
- Abstract PD12-01: PD12-01 Impact of obesity and post-diagnosis weight change on survival in women with breast cancer diagnosed at Smilow Cancer Hospital from 2013-2019 (2023) (0)
- Abstract OT-32-02: Irene study: Phase 2 study of incmga00012 (retifanlimab)and the oncolytic virus pelareorep in metastatic triple negative breast cancer (2021) (0)
- Abstract P2-23-09: Ultra-high Tumor Mutation Burden in Metastatic/Clinically Advanced Breast Cancer (MBC) (2023) (0)
- A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy (2022) (0)
- A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy (2022) (0)
- Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN) (2023) (0)
- Webinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation (2022) (0)
- Abstract P1-09-04: Longitudinal evaluation of taxane-induced neuropathy in early stage breast cancer (2015) (0)
- Abstract P2-13-13: The patient-centered paradox: A US-based survey of physician- and patient-reported experiences with biosimilar trastuzumab (2022) (0)
- Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer (2020) (0)
- A Novel Dietary Intervention to Reduce Chronic Inflammation in Postmenopausal Women (2015) (0)
- Utilization of cancer survivorship services during the COVID-19 pandemic in a tertiary referral center (2022) (0)
- Integrative model for breast cancer survivorship. (2013) (0)
- Abstract PR06: Different places, same problems: Tales of Deep South and Midwestern young African American breast cancer survivorship care (2020) (0)
- Abstract P1-10-10: Radiation Treatment Patterns for Elderly Women with Breast Cancer Brain Metastases (2023) (0)
- Inflammatory and Affective Responses to Acute Resistance Exercise of Varying Loads in Postmenopausal Women. (2019) (0)
- Metastatic breast cancer patient perceptions of somatic tumor genomic testing (2020) (0)
- Patterns of Neuropathy in ALL Patients Treated with Vincristine Based Regimens with and without Tyrosine Kinase Inhibitors (2022) (0)
- Targetable genomic mutations in young women with advanced breast cancer. (2022) (0)
- Abstract C57: Knowledge of breastfeeding to reduce breast cancer risk (2018) (0)
- Racial/ethnic disparities in hospice utilization among Medicare beneficiaries dying from pancreatic cancer. (2019) (0)
- Association of osteprotegerin, bone turnover, and bone loss after adjuvant chemotherapy in early-stage breast cancer. (2013) (0)
- Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma (2023) (0)
- Supporting Women's Health Choices-Challenges Facing Breast Cancer Survivors Today. (2022) (0)
- Goal Attainment Scaling with a Dance-Based Intervention for Breast Cancer Survivors With CIPN: Pilot Study (2023) (0)
- Association of pathological complete response rates and TILs in triple-negative breast cancer patients. (2021) (0)
- Abstract A69: Efficacy of alternative 28-day capecitabine dosing schedule in metastatic breast cancer (2018) (0)
- Effect of neoadjuvant chemotherapy on immune checkpoint expression in breast cancer. (2017) (0)
- LPTO-10. ASSESSMENT OF LEPTOMENINGEAL CARCINOMATOSIS DIAGNOSIS AND OUTCOMES FROM 2005 TO 2015 AT THE OHIO STATE UNIVERSITY (2019) (0)
- The OncoAlert #ASCO21 Picks Track: Metastatic Breast Cancer (Dr.s (0)
- Retrospective cohort study of scalp cooling in breast cancer patients (2023) (0)
- Fractional CO2 laser therapy for genitourinary syndrome of menopause (GSM) in survivors of breast cancer (BC). (2018) (0)
- Abstract P3-07-08: Multi-omic predictor of rapid and late relapse in primary triple negative breast cancer (2019) (0)
- 316P Attitudes towards the use of stereotactic body radiation therapy in oligometastatic breast cancer: Results of an OncoAlert survey (2021) (0)
- Preliminary Efficacy Of A Community-based, Group-mediated Cognitive Behavioral Lifestyle Intervention Among Breast Cancer Survivors (2021) (0)
- Development of automated quantitative multiparameter immunocytochemical profiling of circulating tumor cells (CTCs) in breast cancer (BC). (2012) (0)
- Preliminary efficacy of a community-based, group-mediated cognitive behavioral lifestyle intervention among breast cancer survivors. (2021) (0)
- The Effects of Chemotherapy on Circulating Plasma Omega-9, Omega-3 Fatty Acids and Plasmalogen in Breast Cancer Patients (2022) (0)
- Abstract P2-02-05: Patterns of adjuvant bone modifying agent use in patients with early-stage breast cancer in the United States (2023) (0)
- Metaplastic progression free survival compared to triple negative breast cancer, a retrospective analysis. (2016) (0)
- A troubled heart: Mood disorder history longitudinally predicts faster cardiopulmonary aging in breast cancer survivorship (2023) (0)
- Biomodulation of capecitabine by weekly paclitaxel and carboplatin in patients with advanced solid tumor malignancies: A dose-escalating phase I study. (2009) (0)
- Abstract P6-09-05: Using Mixed Methods to Examine Clinician and Patient Use of Terminology to Describe Trastuzumab Biosimilars (2023) (0)
- The Effects of Chemotherapy on Circulating Plasma Carotenoids and Fat-Soluble Vitamins in Breast Cancer Patients (2021) (0)
- Treatment patterns and medical costs of metastatic breast cancer care in the United States. (2022) (0)
- Socio‐Demographic and Disease Related Factors Associated with Diet Quality Among Adult Cancer Patients (2017) (0)
- Abstract P2-13-06: Living well with advanced breast cancer: A unique multidisciplinary clinic designed to empower and educate patients with metastatic breast cancer (MBC) (2020) (0)
- Hair loss during and after breast cancer therapy (2023) (0)
- Impact of breast cancer treatment on body mass index (BMI) over time. (2015) (0)
- Clinical and genetic risk factors for AI-induced arthralgia. (2014) (0)
- Abstract CT017: A Phase Ib of a combination of two chimeric (Trastuzumab-like and Pertuzumab-like) HER-2 B cell peptide vaccine emulsified in ISA 720 and nor-MDP adjuvant in patients with advanced solid tumors (2019) (0)
- Abstract A55: A prospective geriatric breast cancer cohort study to define unique features and outcomes in older breast cancer patients (2018) (0)
- Effects of Omega-3 Fatty Acids on Insulin Resistance in an Ovariectomized Mouse Model of Diet-Induced Obesity Treated with Chemotherapy (2020) (0)
- The mutational profile of ER-, PR+, HER2- metastatic breast cancer. (2022) (0)
- Effect of Partnered Dance Intervention on Upper Extremity Outcomes for Breast Cancer Survivors With CIPN (2023) (0)
- Patient-centered dosing: oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC) (2022) (0)
- Cardiotoxic safety communications after FDA approval of novel cancer therapies. (2021) (0)
- Depletion of Normal Cells for CTC Enrichment (2016) (0)
- Biomechanical Effect of Music and Dance on Postural Control Among Breast Cancer Survivors With Neuropathy (2023) (0)
- Abstract 2371: Circulating cancer associated cells co-express epithelial and hematopoietic markers in metastatic breast cancer (MBC) patients (pts) (2012) (0)
- Longitudinal Biomechanical Assessment of Arts-Based Balance Interventions for Elderly at Risk of Falling: A 9-month Case Study (2016) (0)
- Limited benefit and high financial burden of drugs used to manage cancer-associated anorexia/cachexia syndrome (CACS). (2021) (0)
- Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control (2022) (0)
- Palliative Care Referral Patterns of Adolescent and Young Adult Patients at a Comprehensive Cancer Center (GP725) (2020) (0)
- Abstract CT033: Phase 1b study of heat shock protein 90 inhibitor onalespib in combination with paclitaxel in patients with advanced, triple-negative breast cancer (NCT02474173) (2016) (0)
- The Effects of Omega-3 Supplementation and Doxorubicin-Based Chemotherapy on the Murine Brain Lipidome (2020) (0)
- Breast Cancer Neoadjuvant Dual HER 2-Targeted TherapyWith Lapatinib and Trastuzumab ImprovesPathologicCompleteResponse inPatientsWith Early Stage HER 2-Positive Breast Cancer : A Meta-Analysis of Randomized Prospective Clinical Trials (2015) (0)
- Serial circulating tumor DNA samples from patients with metastatic breast cancer and BRCA1/2 mutations. (2021) (0)
- Abstract P2-03-03: Incidence of actionable genomic alterations in metastatic breast cancer: A prospective study (2015) (0)
- Abstract 531: Human γδ T cells limit breast tumor growth partly by down regulating cell survival-related molecules and up regulating apoptosis-related molecules in tumor cells (2012) (0)
- Abstract A20: Analysis of tumor infiltrating lymphocytes and expression of PD1 and PD-L1 in breast tumors prior to and after neoadjuvant chemotherapy (2018) (0)
- Clinician perspectives of complementary and integrative medicine (CIM) at an academic cancer center. (2020) (0)
- MYOCARDIAL IMPACT OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) SECRETOMES IN CARDIO-ONCOLOGY PATIENTS (2022) (0)
- Abstract P4-05-02: Machine learning predicts rapid relapse in triple negative breast cancer (2020) (0)
- Online description of services provided in adult survivorship programs across U.S. accredited cancer centers (2023) (0)
- Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increases. (2023) (0)
- A Pill for Sexual Desire in Female Cancer Survivors: Too Good to Be True? (2021) (0)
- Psychosocial Needs of Gynecological Cancer Survivors: Mixed Methods Study (2022) (0)
- Abstract P5-10-03: Perceptions of somatic genomic testing in patients with metastatic breast cancer: Psychosocial factors, emotional well-being, and genetic comprehension (2020) (0)
- Abstract P4-09-08: Examining neurocognitive function in breast-cancer patients after chemotherapy (2022) (0)
- Abstract PO-063: A systematic review of tandem cognitive behavioral therapy and healthy lifestyle interventions on health-related outcomes (2020) (0)
- Sensorimotor Cortical Thickness Changes Following Taxane-Based Chemotherapy: Support for a CNS Role in CIPN? (2023) (0)
- Next Generation Digital PET Neuroimaging: Does the Acquisition Field of View Size Matter? (2016) (0)
- Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer (2021) (0)
- Identification of a SNP cluster associated with taxane-induced peripheral neuropathy risk in patients being treated for breast cancer using GWAS data derived from a large cooperative group trial (2023) (0)
- Improved Overall Image Quality and Lesion Detectability Enabled by High Definition 2mm Voxel Reconstruction: An Intra-individual Comparison Study in Whole Body FDG PET/CT (2016) (0)
- Delay Discounting as a Potential Therapeutic Target for Weight Loss in Breast Cancer Survivors (2022) (0)
- Changes in Serum Fatty Acids and Inflammatory Markers in Postmenopausal Women With Breast Cancer Following Chemotherapy Treatment (2021) (0)
- Longitudinal changes in patient-reported symptoms and physical function during taxane-based chemotherapy in breast cancer patients. (2016) (0)
- Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer Trajectory (2022) (0)
- Barriers and Enablers of Use of a Cardiovascular Health Application in Cancer Survivorship Care (2017) (0)
- Leveraging GWAS Data Derived From a Large Cooperative Group Trial to Identify a SNP Cluster Associated With the Risk of Taxane-induced Peripheral Neuropathy (2021) (0)
- CLO22-079: A Phase II Open-Label Study of Subcutaneous CpG ODN (PF03512676) in Combination With Trastuzumab in Patients With Metastatic Breast Cancer (2022) (0)
- The Association of Serum Inflammatory Markers and Self-Reported Cognitive Outcomes in Women With Breast Cancer Undergoing Chemotherapy (2022) (0)
- Survival outcomes in patients with IDC and ILC breast cancer: A well matched single institution study. (2021) (0)
- Abstract P2-11-07: Endothelial progenitor cells as novel markers of anthracycline induced cardiac injury (2012) (0)
- Genomic risk prediction of aromatase inhibitor-related arthralgias (AIA) in breast cancer (BC) patients using a novel analytical algorithm (NAA). (2017) (0)
- Abstract P2-11-04: Chemotherapy Induces Neuroinflammation and Cognitive Deficits in Female Mice (2012) (0)
- Genetic testing documentation in survivorship care plans in patients with breast cancer. (2021) (0)
- A review of the impact of energy balance on triple-negative breast cancer. (2023) (0)
- Social Support, social ties, and cognitive function of women with breast cancer: findings from the Women’s Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study (2022) (0)
- Applying the Collaborative Care Model to treat depression and anxiety in breast cancer (BC) patients. (2020) (0)
- Abstract 5158: Estrogen receptor β agonists: A novel therapeutic strategy for breast cancer (2020) (0)
- Abstract P1-02-03: Real World Treatment Patterns of Adjuvant Endocrine Therapy and Ovarian Suppression in Premenopausal HR+/HER2+ Breast Cancer (2023) (0)
- Abstract P4-10-17: Alopecia among breast cancer survivors (2022) (0)
- Phase 1 Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines emulsified in Montanide ISA 720VG and nor-MDP Adjuvant in Patients with Advanced Solid Tumors (2019) (0)
This paper list is powered by the following services:
Other Resources About Maryam Lustberg
What Schools Are Affiliated With Maryam Lustberg?
Maryam Lustberg is affiliated with the following schools:
